» Articles » PMID: 36165644

Synbiotic Intervention with Lactobacilli, Bifidobacteria, and Inulin in Healthy Volunteers Increases the Abundance of Bifidobacteria but Does Not Alter Microbial Diversity

Abstract

Synbiotics combine probiotics and prebiotics and are being investigated for potential health benefits. In this single-group-design trial, we analyzed changes in the gut microbiome, stool quality, and gastrointestinal well-being in 15 healthy volunteers after a synbiotic intervention comprising Lacticaseibacillus rhamnosus (LGG), Lactobacillus acidophilus (LA-5), Lacticaseibacillus paracasei subsp. (L. CASEI 431), and Bifidobacterium animalis subsp. BB-12 and 20 g of chicory-derived inulin powder consumed daily for 4 weeks. Fecal samples were collected at baseline and at completion of the intervention, and all participants completed a fecal diary based on the Bristol Stool Scale and recorded their gastrointestinal well-being. No adverse effects were observed after consumption of the synbiotic product, and stool consistency and frequency remained almost unchanged during the trial. Microbiome analysis of the fecal samples was achieved using shotgun sequencing followed by taxonomic profiling. No changes in alpha and beta diversity were seen after the intervention. Greater relative abundances of were observed in 12 subjects, with indigenous bifidobacteria species constituting the main increase. All four probiotic organisms increased in abundance, and L. rhamnosus, B. animalis, and L. acidophilus were differentially abundant, compared to baseline. Comparison of the fecal strains to the B. animalis subsp. BB-12 reference genome and the sequenced symbiotic product revealed only a few single-nucleotide polymorphisms differentiating the probiotic B. animalis subsp. BB-12 from the fecal strains identified, indicating that this probiotic strain was detectable after the intervention. The effects of probiotics/synbiotics are seldom investigated in healthy volunteers; therefore, this study is important, especially considering the safety aspects of multiple probiotics together with prebiotic fiber in consumption by humans. The study explores at the potential of a synbiotic intervention with lactobacilli, bifidobacteria, and inulin in healthy volunteers and tracks the ingested probiotic strain B. animalis subsp. .

Citing Articles

Mechanism of Action and Beneficial Effects of Probiotics in Amateur and Professional Athletes.

Nami Y, Barghi A, Shahgolzari M, Salehian M, Haghshenas B Food Sci Nutr. 2025; 13(1):e4658.

PMID: 39803224 PMC: 11717059. DOI: 10.1002/fsn3.4658.


The potential preventive effect of probiotics, prebiotics, and synbiotics on cardiovascular risk factors through modulation of gut microbiota: A review.

Ghanbari F, Hasani S, Aghili Z, Asgary S Food Sci Nutr. 2024; 12(7):4569-4580.

PMID: 39055176 PMC: 11266939. DOI: 10.1002/fsn3.4142.


Cross-feeding of bifidobacteria promotes intestinal homeostasis: a lifelong perspective on the host health.

Xiao M, Zhang C, Duan H, Narbad A, Zhao J, Chen W NPJ Biofilms Microbiomes. 2024; 10(1):47.

PMID: 38898089 PMC: 11186840. DOI: 10.1038/s41522-024-00524-6.


The effects of hydrolyzed protein on macronutrient digestibility, fecal metabolites and microbiota, oxidative stress and inflammatory biomarkers, and skin and coat quality in adult dogs.

Hsu C, Marx F, Guldenpfennig R, Valizadegan N, de Godoy M J Anim Sci. 2024; 102.

PMID: 38442226 PMC: 10959486. DOI: 10.1093/jas/skae057.


Gut Microbiota-Gut Metabolites and Infection: Approaching Sustainable Solutions for Therapy.

Gurung B, Stricklin M, Wang S Metabolites. 2024; 14(1).

PMID: 38276309 PMC: 10819375. DOI: 10.3390/metabo14010074.

References
1.
Roberfroid M . Introducing inulin-type fructans. Br J Nutr. 2005; 93 Suppl 1:S13-25. DOI: 10.1079/bjn20041350. View

2.
Fernandes A, Reid J, Macklaim J, McMurrough T, Edgell D, Gloor G . Unifying the analysis of high-throughput sequencing datasets: characterizing RNA-seq, 16S rRNA gene sequencing and selective growth experiments by compositional data analysis. Microbiome. 2014; 2:15. PMC: 4030730. DOI: 10.1186/2049-2618-2-15. View

3.
Matsuoka K, Kanai T . The gut microbiota and inflammatory bowel disease. Semin Immunopathol. 2014; 37(1):47-55. PMC: 4281375. DOI: 10.1007/s00281-014-0454-4. View

4.
Bolger A, Lohse M, Usadel B . Trimmomatic: a flexible trimmer for Illumina sequence data. Bioinformatics. 2014; 30(15):2114-20. PMC: 4103590. DOI: 10.1093/bioinformatics/btu170. View

5.
Gloor G, Macklaim J, Pawlowsky-Glahn V, Egozcue J . Microbiome Datasets Are Compositional: And This Is Not Optional. Front Microbiol. 2017; 8:2224. PMC: 5695134. DOI: 10.3389/fmicb.2017.02224. View